Sự ức chế sự phát triển của tế bào T do sự chuyển hóa tryptophan của đại thực bào

Fazekas de St. Groth, 1998, The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity, Immunol Today, 19, 448, 10.1016/S0167-5699(98)01328-0

Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588

Munn, 1993, Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by interferon γ, Cancer Res, 53, 2603

Munn, 1996, Selective activation-induced apoptosis of peripheral T cells imposed by macrophages: a potential mechanism of antigen-specific peripheral lymphocyte deletion, J Immunol, 156, 523, 10.4049/jimmunol.156.2.523

Shimizu, 1978, Indoleamine 2,3-dioxygenase: purification and some properties, J Biol Chem, 253, 4700, 10.1016/S0021-9258(17)30447-7

Carlin, 1989, Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes, J Leukoc Biol, 45, 29, 10.1002/jlb.45.1.29

Werner, 1987, Human macrophages degrade tryptophan upon induction by interferon-γ, Life Sci, 41, 273, 10.1016/0024-3205(87)90149-4

Taylor, 1991, Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism, FASEB J, 5, 2516, 10.1096/fasebj.5.11.1907934

Pfefferkorn, 1984, Interferon γ blocks the growth of Toxoplasma gondiiin human fibroblasts by inducing the host cells to degrade tryptophan, Proc Natl Acad Sci USA, 81, 908, 10.1073/pnas.81.3.908

Gupta, 1994, Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts, Infect Immun, 62, 2277, 10.1128/iai.62.6.2277-2284.1994

Daubener, 1995, Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasmaantigen-specific T-cell clones, Immunol, 86, 79

Daubener, 1996, Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-γ and tumor necrosis factor-α, Eur J Immunol, 26, 487, 10.1002/eji.1830260231

Nagineni, 1996, Mechanisms of interferon-induced inhibition of Toxoplasma gondiireplication in human retinal pigment epithelial cells, Infect Immun, 64, 4188, 10.1128/iai.64.10.4188-4196.1996

Aune, 1989, Inhibition of tumor cell growth by interferon-γ is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide, J Clin Invest, 84, 863, 10.1172/JCI114247

Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191

Cady, 1991, 1-methyl-d,l-tryptophan, β-(3-benzofuranyl)-d,l-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-d,l-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase, Arch Biochem Biophys, 291, 326, 10.1016/0003-9861(91)90142-6

Southan, 1996, Structural requirements of the competitive binding site of recombinant human indoleamine 2,3-dioxygenase, Med Chem Res, 1996, 343

Moriya, 1975, A facile synthesis of 6-chloro-d-tryptophan, Bull Chem Soc Japan, 48, 2217, 10.1246/bcsj.48.2217

Munn, 1987, Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma, Cancer Res, 47, 6600

Sono, 1980, Indoleamine 2,3-dioxygenase: equilibrium studies of the tryptophan binding to the ferric, ferrous, and co-bound enzymes, J Biol Chem, 255, 1339, 10.1016/S0021-9258(19)86035-0

Bloxam, 1974, Error in the determination of tryptophan by method of Denckla and Dewey. A revised procedure, Anal Biochem, 60, 621, 10.1016/0003-2697(74)90275-9

Yamamoto, 1967, Tryptophan pyrrolase of rabbit intestine: d- and l-tryptophan-cleaving enzyme or enzymes, J Biol Chem, 242, 5260, 10.1016/S0021-9258(18)99420-2

Dai, 1990, Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxygenase cDNA, Biochem Biophys Res Commun, 168, 1, 10.1016/0006-291X(90)91666-G

Munn, 1996, Recombinant human macrophage colony-stimulating factor in nonhuman primates: Selective expansion of a CD16+monocyte subset with phenotypic similarity to primate natural killer cells, Blood, 88, 1215, 10.1182/blood.V88.4.1215.bloodjournal8841215

Koide, 1994, The signal transduction mechanism responsible for gamma interferon-induced indoleamine 2,3-dioxygenase gene expression, Infect Immun, 62, 948, 10.1128/iai.62.3.948-955.1994

Dai, 1990, Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-γ, J Biol Chem, 265, 19871, 10.1016/S0021-9258(17)45453-6

Chon, 1996, Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-γ-inducible expression of human indoleamine 2,3-dioxygenase gene, J Biol Chem, 271, 17247, 10.1074/jbc.271.29.17247

Stout, 1996, The many roles of CD40 in cell-mediated inflammatory responses, Immunol Today, 17, 487, 10.1016/0167-5699(96)10060-I

Crabtree, 1989, Contingent genetic regulatory events in T lymphocyte activation, Science, 243, 355, 10.1126/science.2783497

Medawar, 1953, Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates, Symp Soc Exp Biol, 7, 320

Kamimura, 1991, Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta, Acta Med Okayama, 45, 135

Yoshida, 1980, Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice, Arch Biochem Biophys, 203, 343, 10.1016/0003-9861(80)90185-X

Moffett, 1994, Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system, Cell Tissue Res, 278, 461, 10.1007/BF00331364

Espey, 1996, Localization of quinolinic acid in the murine AIDS model of retrovirus-induced immunodeficiency: implications for neurotoxicity and dendritic cell immunopathogenesis, AIDS, 10, 151, 10.1097/00002030-199602000-00004

Espey, 1995, Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide-stimulated mice, J Leukoc Biol, 57, 199, 10.1002/jlb.57.2.199

Yoshida, 1981, Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung, Arch Biochem Biophys, 212, 629, 10.1016/0003-9861(81)90406-9

Malina, 1996, Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye, Graefe's Arch Clin Exp Ophthalmol, 234, 457, 10.1007/BF02539413

Casciari, 1988, Glucose diffusivity in multicellular tumor spheroids, Cancer Res, 48, 3905

Li, 1982, The glucose distribution in 9L rat brain multicell tumor spheroids and its effect on cell necrosis, Cancer, 50, 2066, 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X

Fleckner, 1995, Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines, Cytokine, 7, 70, 10.1006/cyto.1995.1009

Smith, 1988, Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation, Proc Natl Acad Sci USA, 85, 9341, 10.1073/pnas.85.23.9341

Dauphinais, 1977, PHA stimulation of human lymphocytes during amino acid deprivation: protein, RNA, and DNA synthesis, J Cell Physiol, 91, 357, 10.1002/jcp.1040910305

Woolley, 1974, Effects of tryptophan deprivation on L1210 cells in culture, Cancer Res, 34, 1010

Brunner, 1973, Regulation of DNA synthesis by amino acid limitation, Cancer Res, 33, 29

Tobey, 1971, Isoleucine-mediated regulation of genome replication in various mammalian cell lines, Cancer Res, 31, 46

Cherwinski, 1995, The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis, J Pharmacol Exp Ther, 275, 1043

Terada, 1995, Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes, J Immunol, 155, 3418, 10.4049/jimmunol.155.7.3418

Laliberte, 1998, Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes, Blood, 91, 2896, 10.1182/blood.V91.8.2896.2896_2896_2904

DeSilva, 1991, Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation, J Immunol, 147, 3261, 10.4049/jimmunol.147.10.3261

Bird, 1998, Helper T cell differentiation is controlled by the cell cycle, Immunity, 9, 229, 10.1016/S1074-7613(00)80605-6

Oehen, 1998, Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division, J Immunol, 161, 5338, 10.4049/jimmunol.161.10.5338

Babitzke, 1997, Regulation of tryptophan biosynthesis: trp-ing the TRAP or how Bacillus subtilisreinvented the wheel, Molec Microbiol, 26, 1, 10.1046/j.1365-2958.1997.5541915.x

Knox, 1951, The adaptive increase of the tryptophan peroxidase-oxidase system of liver, Science, 113, 237, 10.1126/science.113.2931.237

Schwartz, 1996, Models of T cell anergy: is there a common molecular mechanism?, J Exp Med, 184, 1, 10.1084/jem.184.1.1